Difelikefalin for the treatment of moderate-to-severe pruritus associated with chronic kidney disease on hemodialysis

By sjmartinez • April 4, 2023

Rastogi A, Fishbane S, Lerma E. Difelikefalin for the treatment of moderate-to-severe pruritus associated with chronic kidney disease on hemodialysis. Expert Rev Clin Pharmacol. 2023 Apr 3. doi: 10.1080/17512433.2023.2197209. Epub ahead of print. PMID: 37010031.

Tags: Chronic kidney disease, chronic kidney disease-associated pruritus, difelikefalin, efficacy, kappa opioid receptor, Nephrology, opioids, pruritus, Publications, safety

Proposed US Legislation to Pay Kidney Donors: Counter-productive and Against Global Ethical Standards

Capron AM, Danovitch GM, Cooper M, Ascher NL, Delmonico FL. Proposed US Legislation to Pay Kidney Donors: Counter-productive and Against Global Ethical Standards. Transplantation. 2024[...]

Fiery Connections: Macrophage-Mediated Inflammation, the Journey from Obesity to Type 2 Diabetes Mellitus and Diabetic Kidney Disease

Sinha SK, Carpio MB, Nicholas SB. Fiery Connections: Macrophage-Mediated Inflammation, the Journey from Obesity to Type 2 Diabetes Mellitus and Diabetic Kidney Disease. Biomedicines. 2024[...]

Microvascular Inflammation of Kidney Allografts and Clinical Outcomes

Sablik M, Sannier A, Raynaud M, Goutaudier V, Divard G, Astor BC, Weng P, Smith J, Garro R, Warady BA, Zahr RS, Twombley K, Dharnidharka[...]